The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic utility of ctDNA detection in the monarchE trial of adjuvant abemaciclib plus endocrine therapy (ET) in HR+, HER2-, node-positive, high-risk early breast cancer (EBC).
 
Sherene Loi
Honoraria - Mersana; MSD Oncology; Novartis; Roche/Genentech
Consulting or Advisory Role - Aduro Biotech (Inst); AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Lilly (Inst); G1 Therapeutics (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); PUMA Biotechnology (Inst); Roche/Genentech (Inst); Seagen (Inst); Silverback Therapeutics (Inst); Tallac Therapeutics (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - BMS
Other Relationship - Roche Medical writing support
 
Stephen R. D. Johnston
Honoraria - AstraZeneca; Lilly; Pfizer
Consulting or Advisory Role - Genzyme; Lilly; Pfizer; Puma Biotechnology
Research Funding - Pfizer (Inst)
Expert Testimony - Novartis
 
Carlos L. Arteaga
Stock and Other Ownership Interests - Provista Diagnostics
Consulting or Advisory Role - Arvinas; Astrazeneca; Athenex; Daiichi Sankyo; Immunomedics; Lilly; Merck; Novartis; Origimed; Puma Biotechnology; Sanofi; Taiho Pharmaceutical
Research Funding - Lilly; Pfizer
Other Relationship - Susan G. Komen for the Cure
(OPTIONAL) Uncompensated Relationships - Susan G. Komen for the Cure
 
Stephanie L. Graff
Stock and Other Ownership Interests - HCA Healthcare
Honoraria - Academy for Continued Healthcare Learning; DAVA Oncology; IntegrityCE; Med IQ; Medical Educator Consortium; MedPage Today; MJH Life Sciences; Remedy Health; WebMD/Medscape; Wolters Kluwer
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Genentech; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Seagen
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Loxo/Lilly; Novartis; Paxman
Other Relationship - Dr. Susan Love Foundation for Breast Cancer Research
 
Sarat Chandarlapaty
Stock and Other Ownership Interests - Odyssey Biosciences; Totus Medicines
Consulting or Advisory Role - AstraZeneca/MedImmune; Boxer Capital; Inivata; Lilly; Novartis; Paige.ai; Prelude Therapeutics; SAGA Diagnostics; Sanofi
Research Funding - Ambryx (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Novartis (Inst); Paige.ai (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for (1) targeting mutant ER with ER PROTACS and (2) targeting CDK4/6 with CDK4/6 PROTACS (Inst)
Travel, Accommodations, Expenses - Novartis Institutes for BioMedical Research
Other Relationship - Peerview; Targeted Oncology; WebMD
(OPTIONAL) Uncompensated Relationships - Odyssey Biosciences; Totus Medicines
 
Matthew P. Goetz
Consulting or Advisory Role - ARC Therapeutics (Inst); AstraZeneca (Inst); BioTheryX; Blueprint Medicines (Inst); Engage Health Media (Inst); Genzyme (Inst); Laekna Therapeutics; Lilly (Inst); Novartis (Inst); Rna Diagnostics (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Tersera
Research Funding - AstraZeneca (Inst); Atossa Genetics (Inst); Lilly (Inst); Loxo (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Development of Human Tumor Xenografts from Women with Breast Cancer Treated with Neoadjuvant Chemotherapy (Inst); Methods and Materials for Assessing Chemotherapy Responsiveness and Treating Cancer; METHODS AND MATERIALS FOR USING BUTYRYLCHOLINESTERASES TO TREAT CANCER
Travel, Accommodations, Expenses - Lilly (Inst)
 
Christine Desmedt
Consulting or Advisory Role - AstraZeneca (Inst); Lilly (Inst)
Expert Testimony - Lilly (Inst)
 
Hironobu Sasano
No Relationships to Disclose
 
Deli Liu
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Vanessa Rodrik-Outmezguine
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Anthony Sireci
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Consulting or Advisory Role - Aster Insights; Biocartis
 
Cynthia Sandoval
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Helen H Won
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Lacey M Litchfield
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Nicholas C. Turner
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Guardant Health; Inivata; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Relay Therapeutics; Repare Therapeutics; Roche
Research Funding - AstraZeneca (Inst); Guardant Health (Inst); Inivata (Inst); InVitae (Inst); Merck Sharpe and Dohme (Inst); Natera (Inst); Personalis (Inst); Pfizer (Inst); Roche (Inst)